Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Constipation - Overview
Constipation - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Constipation - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Constipation - Companies Involved in Therapeutics Development
Allergan Plc
Ardelyx Inc
Bausch Health Companies Inc
Braintree Laboratories Inc
Dong-A ST Co Ltd
Enterin Inc
Inhibikase Therapeutics Inc
Ironwood Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Mallinckrodt Plc
NGM Biopharmaceuticals Inc
RaQualia Pharma Inc
Renexxion LLC
Sanwa Kagaku Kenkyusho Co Ltd
Synthetic Biologics Inc
Yuhan Corp
Zensun (Shanghai) Sci & Tech Co Ltd
Constipation - Drug Profiles
5-BIOP - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biologic for Irritable Bowel Syndrome with Constipation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLI-400 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BLI-801 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DA-6886 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ENT-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IkT-148009 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lactulose 1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
liclotide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lovastatin MR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lubiprostone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mizagliflozin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ropride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NGM-282 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
plecatide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RQ-00000010 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
tepanor - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
YH-12852 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZS-06 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Constipation - Dormant Projects
Constipation - Discontinued Products
Constipation - Product Development Milestones
Featured News & Press Releases
Jul 22, 2019: Ironwood Pharmaceuticals Allergan provides update on its ANDA Lawsuit
Jun 26, 2019: Knight announces filing of New Drug Submission for Ibsrela in Cada
Jun 20, 2019: Ironwood and Allergan’s LINZESS trial meets primary endpoint
May 14, 2019: Salix Pharmaceuticals presents data on TRULANCE at Digestive Disease Week
May 09, 2019: Ironwood Pharmaceuticals to highlight liclotide data at Digestive Disease Week 2019
Jan 18, 2019: Linzess (liclotide) approved in Chi for the treatment of irritable bowel syndrome with constipation
Jan 04, 2019: Ironwood and Allergan settle Linzess patent litigation with Mylan
Jan 03, 2019: Synthetic Biologics announces first two patients enrolled in phase 2b investigator-sponsored
Dec 17, 2018: Cipher Pharmaceuticals announces PLECATIDE accepted for review by Health Cada
Nov 13, 2018: Ardelyx announces FDA acceptance of the filing of its New Drug Application for Tepanor for the treatment of patients with IBS-C
Oct 25, 2018: Synergy Pharmaceuticals provides business update
Oct 08, 2018: Synergy pharmaceuticals presents new alyses supporting the use of TRULANCE (Plecatide) in two patient populations at the American College of Gastroenterology (ACG) Annual Scientific Meeting
Oct 08, 2018: Ironwood Pharmaceuticals presenting Liclotide Data at the American College of Gastroenterology 2018 Annual Scientific Meeting
Oct 08, 2018: Ardelyx showcases new data from T3MPO-3 long-term safety trial of Tepanor for IBS-C in presidential poster at ACG 2018 Annual Meeting
Oct 01, 2018: Synergy Pharmaceuticals to present new alyses of TRULANCE (Plecatide) at the American College of Gastroenterology (ACG) Annual Scientific Meeting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Constipation, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Top 10 Targets, H2 2019
Number of Products by Stage and Top 10 Targets, H2 2019
Number of Products by Top 10 Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables


Number of Products under Development for Constipation, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Constipation - Pipeline by Allergan Plc, H2 2019
Constipation - Pipeline by Ardelyx Inc, H2 2019
Constipation - Pipeline by Bausch Health Companies Inc, H2 2019
Constipation - Pipeline by Braintree Laboratories Inc, H2 2019
Constipation - Pipeline by Dong-A ST Co Ltd, H2 2019
Constipation - Pipeline by Enterin Inc, H2 2019
Constipation - Pipeline by Inhibikase Therapeutics Inc, H2 2019
Constipation - Pipeline by Ironwood Pharmaceuticals Inc, H2 2019
Constipation - Pipeline by Kissei Pharmaceutical Co Ltd, H2 2019
Constipation - Pipeline by Mallinckrodt Plc, H2 2019
Constipation - Pipeline by NGM Biopharmaceuticals Inc, H2 2019
Constipation - Pipeline by RaQualia Pharma Inc, H2 2019
Constipation - Pipeline by Renexxion LLC, H2 2019
Constipation - Pipeline by Sanwa Kagaku Kenkyusho Co Ltd, H2 2019
Constipation - Pipeline by Synthetic Biologics Inc, H2 2019
Constipation - Pipeline by Yuhan Corp, H2 2019
Constipation - Pipeline by Zensun (Shanghai) Sci & Tech Co Ltd, H2 2019
Constipation - Dormant Projects, H2 2019
Constipation - Dormant Projects, H2 2019 (Contd..1), H2 2019
Constipation - Discontinued Products, H2 2019